HAEMONETICS CORP
Financial highlights
| Metric | FY 03/28/26 | FY 03/29/25 | FY 03/30/24 | FY 04/01/23 | FY 04/02/22 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.3 | $1.4 | $1.3 | $1.2 | $1.0 |
| Operating income | $0.2 | $0.2 | $0.2 | $0.2 | $0.1 |
| Net income | $0.1 | $0.2 | $0.1 | $0.1 | $<0.1 |
| Balance Sheet | |||||
| Total debt | $1.2 | $1.2 | — | — | — |
| Cash Flow Statement | |||||
| Free cash flow | $0.3 | $0.1 | $0.1 | $0.1 | $0.1 |
| Share repurchases | $0.2 | $0.2 | $0.0 | $0.1 | $0.0 |
Shares outstanding 45.5M · Free float 98.0%
Annual filing data through FY ended March 28, 2026; float as of September 19, 2026.